Male Infertility Treatment in New Jersey | Damien Fertility Partners
Male infertility is a factor in nearly half of all couples who struggle to conceive, yet it remains one of the most under-evaluated parts of the fertility workup. Research consistently shows that male factor contributes to approximately 40% of infertility cases on its own, with an additional 20% involving both male and female factors. That means the male partner plays a role in up to 60% of couples seeking treatment.
Despite those numbers, fertility care has historically been framed around the female partner. Many couples spend months or years pursuing testing and treatment for the woman before the man’s contribution is evaluated. At Damien Fertility Partners, the male workup is treated as a clinical priority from the first visit. Both partners are encouraged to attend the initial consultation, and semen analysis is ordered early in the diagnostic process.
The practice is led by two board-certified reproductive endocrinologists, including Dr. Barry Perlman, whose clinical interests include male factor infertility and the effects of endocrine disruptors on reproductive health. The practice operates from offices in Shrewsbury, Newark, and Jersey City.
What Causes Male Infertility
Male infertility is not a single diagnosis. It describes a range of conditions that reduce the quantity, quality, or delivery of sperm.
Low sperm count (oligospermia) means fewer than 15 million sperm per milliliter of semen. In severe cases, the ejaculate may contain no sperm at all, a condition called azoospermia. Causes range from hormonal imbalances and varicocele (enlarged veins in the scrotum) to genetic factors and prior medical treatments.
Poor sperm motility (asthenospermia) refers to sperm that do not swim well enough to reach and fertilize the egg. Motility is graded by the percentage of sperm that move progressively forward, and a result below 32% is considered below normal according to World Health Organization reference values.
Abnormal sperm morphology (teratospermia) describes sperm with structural defects in the head, midpiece, or tail that can impair fertilization. While morphology alone is rarely the sole cause of infertility, it can reduce the odds of natural conception and influence treatment decisions.
Obstructive causes include blockages in the vas deferens, epididymis, or ejaculatory ducts that prevent sperm from reaching the ejaculate. These may result from prior surgery, infection, or congenital absence of the vas deferens, a condition linked to the CFTR gene associated with cystic fibrosis.
Hormonal and systemic factors such as low testosterone, elevated prolactin, thyroid dysfunction, and exposure to environmental endocrine disruptors can all affect sperm production. Dr. Perlman has published peer-reviewed research on the relationship between endocrine disruptors and fertility in ASRM’s Fertility and Sterility Reports, a topic with growing clinical relevance as environmental exposures increase.
The Male Fertility Workup
A thorough male infertility evaluation begins with a semen analysis, the single most informative test in male reproductive medicine. The analysis measures sperm count, motility, morphology, volume, and pH. At Damien Fertility Partners, the lab team includes a dedicated andrologist who processes and evaluates all semen specimens.
If the semen analysis reveals abnormalities, additional testing may include hormonal panels (testosterone, FSH, LH, estradiol, prolactin, thyroid function), genetic testing (karyotype, Y chromosome microdeletion, CFTR screening), scrotal ultrasound to evaluate for varicocele or structural abnormalities, and, in some cases, a post-ejaculatory urinalysis to check for retrograde ejaculation.
The reproductive endocrinologist interprets these results as part of the couple’s combined diagnostic picture. Male factor does not exist in isolation. The treatment plan accounts for both partners’ test results, ages, and reproductive goals. In some cases, the RE will coordinate with a urologist for surgical evaluation or intervention, while managing the overall fertility treatment plan in-house.
For more on what to expect from the evaluation, see the practice’s post on why the male workup matters.
Treatment Options for Male Infertility
Treatment depends on the diagnosis, the severity of the findings, and the female partner’s fertility status.
Lifestyle and medical optimization. For mild abnormalities, the RE may recommend changes to modifiable factors: reducing heat exposure to the testes, eliminating tobacco use and excessive alcohol intake, improving diet and exercise habits, and reviewing medications that may impair sperm production. Hormonal therapy (clomiphene citrate, hCG, or FSH) may be prescribed for patients with correctable hormonal deficiencies.
Intrauterine insemination (IUI). When sperm count and motility are mildly reduced but sufficient (generally at least 5 to 10 million total motile sperm after processing), IUI places a concentrated sperm sample directly into the uterus at the time of ovulation. This bypasses the cervix and reduces the distance sperm must travel.
IVF with ICSI. For moderate to severe male factor, IVF combined with intracytoplasmic sperm injection (ICSI) is the most effective treatment. ICSI involves injecting a single sperm directly into a mature egg, bypassing all natural barriers to fertilization. This technique allows pregnancy even with very low sperm counts, poor motility, or high morphological abnormality rates. ICSI is performed in the practice’s CAP-accredited, FDA-accredited embryology lab.
Surgical sperm retrieval. For patients with obstructive or non-obstructive azoospermia, sperm can sometimes be obtained surgically through procedures like testicular sperm extraction (TESE) or microsurgical epididymal sperm aspiration (MESA). These procedures are typically coordinated with a urologist, and the retrieved sperm is used with ICSI during an IVF cycle.
Donor sperm. When male factor infertility cannot be resolved through the above approaches, or when the patient prefers this path, donor sperm is available through the practice’s partnerships with several sperm banks. Donor sperm can be used with IUI or IVF.
The Lab’s Role in Male Factor Treatment
The embryology lab is directly involved in every male factor treatment that goes beyond timed intercourse. Semen processing for IUI, ICSI for IVF, and handling surgically retrieved sperm all require technical precision and specialized training.
At Damien Fertility Partners, the lab holds accreditation from the College of American Pathologists (CAP), the FDA, and the NJ State Department of Health, all with zero deficiencies. The lab uses CHLOE, an AI-powered embryo-monitoring system from Fairtility. After ICSI fertilization, CHLOE continuously tracks embryo development in the incubator, producing a developmental timeline that the physician reviews with the patient.
In 2023, the practice reported a 100% elective single-embryo transfer rate for patients under 35 and an 81.8% live-birth rate per new patient in that age group, according to SART data. Clinic-to-clinic comparisons should be interpreted with caution due to differences in patient populations.
Insurance and Financial Support
New Jersey’s fertility insurance mandate requires qualifying group health plans covering 50 or more employees to cover up to four completed egg retrievals per lifetime. The 2024 expansion removed restrictions based on age, relationship status, and sexual orientation. Male fertility testing, including semen analysis and hormonal panels, is typically covered as part of the infertility diagnostic workup.
Damien Fertility Partners works with most insurance carriers and employs a dedicated bilingual Insurance Verification Specialist. Financing through CapexMD is available for patients who need it, with loan pre-approval within 24 hours.
Frequently Asked Questions
How common is male infertility?
Male factor contributes to approximately 40% of infertility cases, with an additional 20% involving both partners. That means male reproductive health plays a role in up to 60% of couples who have difficulty conceiving.
What is the first test for male infertility?
A semen analysis is the first and most informative test. It measures sperm count, motility, morphology, volume, and pH. At Damien Fertility Partners, a dedicated andrologist evaluates all semen specimens in the practice’s CAP-accredited lab.
Can male infertility be treated without IVF?
In some cases, yes. Mild male factors may respond to lifestyle changes, hormonal therapy, or IUI. However, moderate to severe male factors, including very low sperm counts or azoospermia, typically require IVF with ICSI for the best chance of pregnancy.
What is ICSI, and when is it used?
ICSI (intracytoplasmic sperm injection) is a laboratory technique where a single sperm is injected directly into a mature egg. It is used during IVF when sperm count, motility, or morphology are too compromised for conventional fertilization. ICSI allows pregnancy even with very few viable sperm.
Does Damien Fertility Partners have a male infertility specialist?
Dr. Barry Perlman is board-certified in REI with a specific clinical focus on male factor infertility and the effects of endocrine disruptors on reproductive health. He has published peer-reviewed research on endocrine disruptors and fertility in ASRM’s Fertility and Sterility Reports. Dr. Perlman sees patients in person and offers virtual consultations.
Get Evaluated Together
Male infertility is treatable in the majority of cases, and the earlier it is identified, the more options are available. At Damien Fertility Partners, both partners are evaluated from the outset, and the combined diagnostic picture informs treatment decisions.
The practice brings board-certified reproductive endocrinologists, a dedicated andrologist, a CAP-accredited lab with ICSI capability and AI-assisted embryo monitoring, and bilingual care to three New Jersey locations. Request a consultation with Dr. Damien or Dr. Perlman, or visit damienfertilitypartners.com to schedule your first appointment.